These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24127779)

  • 21. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
    Rossouw JE; Prentice RL; Manson JE; Wu L; Barad D; Barnabei VM; Ko M; LaCroix AZ; Margolis KL; Stefanick ML
    JAMA; 2007 Apr; 297(13):1465-77. PubMed ID: 17405972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of hormone therapy with blood pressure control in postmenopausal women with hypertension: a secondary analysis of the Women's Health Initiative clinical trials.
    Jiang X; Aragaki AK; Nudy M; Manson JE; Shadyab AH; Wild RA; Valdiviezo C; Gass M; Martin LW; Pan K; Stefanick ML; Robbins JA; Schnatz PF
    Menopause; 2023 Jan; 30(1):28-36. PubMed ID: 36256926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gynecologists' attitudes towards hormone therapy in the post "Women's Health Initiative" study era.
    Nassar AH; Abd Essamad HM; Awwad JT; Khoury NG; Usta IM
    Maturitas; 2005 Sep; 52(1):18-25. PubMed ID: 16143222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Women's Health Initiative clinical trials: potential interactive effect of calcium and vitamin D supplementation with hormonal therapy on cardiovascular disease.
    Jiang X; Nudy M; Aragaki AK; Robbins JA; Manson JE; Stefanick ML; OʼSullivan DM; Shikany JM; LeBlanc ES; Kelsey AM; Cauley J; Martin LW; Payne ME; Johnson KC; Howard B; Schnatz PF
    Menopause; 2019 Aug; 26(8):841-849. PubMed ID: 31145202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Menopausal Hormone Therapy and Risks of First Hospitalized Heart Failure and its Subtypes During the Intervention and Extended Postintervention Follow-up of the Women's Health Initiative Randomized Trials.
    Liu L; Klein L; Eaton C; Panjrath G; Martin LW; Chae CU; Greenland P; Lloyd-Jones DM; Wactawski-Wende J; Manson JE
    J Card Fail; 2020 Jan; 26(1):2-12. PubMed ID: 31536806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study.
    Shufelt C; Bairey Merz CN; Pettinger MB; Choi L; Chlebowski R; Crandall CJ; Liu S; Lane D; Prentice R; Manson JE;
    Menopause; 2018 Sep; 25(9):985-991. PubMed ID: 29738414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproductive and menstrual factors and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women.
    Kabat GC; Kim MY; Woods NF; Habel LA; Messina CR; Wactawski-Wende J; Stefanick ML; Chlebowski RT; Wassertheil-Smoller S; Rohan TE
    Cancer Causes Control; 2011 Oct; 22(10):1415-24. PubMed ID: 21750889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of conjugated equine estrogen on stroke in the Women's Health Initiative.
    Hendrix SL; Wassertheil-Smoller S; Johnson KC; Howard BV; Kooperberg C; Rossouw JE; Trevisan M; Aragaki A; Baird AE; Bray PF; Buring JE; Criqui MH; Herrington D; Lynch JK; Rapp SR; Torner J;
    Circulation; 2006 May; 113(20):2425-34. PubMed ID: 16702472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined conjugated esterified estrogen plus methyltestosterone supplementation and risk of breast cancer in postmenopausal women.
    Kabat GC; Kamensky V; Heo M; Bea JW; Hou L; Lane DS; Liu S; Qi L; Simon MS; Wactawski-Wende J; Rohan TE
    Maturitas; 2014 Sep; 79(1):70-6. PubMed ID: 25011395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Women's Health Initiative trials of menopausal hormone therapy: lessons learned.
    Manson JE; Bassuk SS; Kaunitz AM; Pinkerton JV
    Menopause; 2020 Aug; 27(8):918-928. PubMed ID: 32345788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Women's Health Initiative Memory Study: findings and implications for treatment.
    Craig MC; Maki PM; Murphy DG
    Lancet Neurol; 2005 Mar; 4(3):190-4. PubMed ID: 15721829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The women's health initiative: lessons learned.
    Prentice RL; Anderson GL
    Annu Rev Public Health; 2008; 29():131-50. PubMed ID: 18348708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause.
    Langer RD
    Climacteric; 2010 Aug; 13(4):303-6. PubMed ID: 20540591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative review of the risks and benefits of hormone replacement therapy regimens.
    Warren MP
    Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conjugated equine estrogen and medroxyprogesterone acetate are associated with decreased risk of breast cancer relative to bioidentical hormone therapy and controls.
    Zeng Z; Jiang X; Li X; Wells A; Luo Y; Neapolitan R
    PLoS One; 2018; 13(5):e0197064. PubMed ID: 29768475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hormone replacement therapy and cognitive function].
    Huang CP; Hong CT; Huang IT
    Acta Neurol Taiwan; 2006 Dec; 15(4):273-7. PubMed ID: 17214093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of stroke in healthy postmenopausal women during and after hormone therapy: a meta-analysis.
    Gu H; Zhao X; Zhao X; Yang Y; Lv X
    Menopause; 2014 Nov; 21(11):1204-10. PubMed ID: 24686450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conjugated equine estrogens and peripheral arterial disease risk: the Women's Health Initiative.
    Hsia J; Criqui MH; Herrington DM; Manson JE; Wu L; Heckbert SR; Allison M; McDermott MM; Robinson J; Masaki K;
    Am Heart J; 2006 Jul; 152(1):170-6. PubMed ID: 16824852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
    Prentice RL; Langer RD; Stefanick ML; Howard BV; Pettinger M; Anderson GL; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
    Am J Epidemiol; 2006 Apr; 163(7):589-99. PubMed ID: 16484450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.